{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:28:46Z","timestamp":1791268126781,"version":"4.1.0"},"reference-count":20,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.3892\/mco.2013.134","type":"journal-article","created":{"date-parts":[[2013,5,27]],"date-time":"2013-05-27T07:48:57Z","timestamp":1369640937000},"page":"675-679","source":"Crossref","is-referenced-by-count":55,"title":["Increased IL-17 production correlates with immunosuppression involving myeloid-derived suppressor cells and nutritional impairment in patients with various gastrointestinal cancers"],"prefix":"10.3892","volume":"1","author":[{"given":"TAKASHI","family":"YAZAWA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MASAHIKO","family":"SHIBATA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KENJI","family":"GONDA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TAKESHI","family":"MACHIDA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SATOSHI","family":"SUZUKI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AKIRA","family":"KENJO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"IZUMI","family":"NAKAMURA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TAKAO","family":"TSUCHIYA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YOSHIHISA","family":"KOYAMA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KENICHI","family":"SAKURAI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TATSUO","family":"SHIMURA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RYOUICHI","family":"TOMITA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HITOSHI","family":"OHTO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MITSUKAZU","family":"GOTOH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SEIICHI","family":"TAKENOSHITA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2013,5,27]]},"reference":[{"key":"key20180107151614_b1-mco-01-04-0675","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"key":"key20180107151614_b2-mco-01-04-0675","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+effector T cells develop via a lineage distinct from the T helper type 1 and type 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat Immunol"},{"key":"key20180107151614_b3-mco-01-04-0675","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20041257","article-title":"IL-23 drives a pathogenic T cell population that induces autoimmune inflammation","volume":"201","author":"Langrish","year":"2005","journal-title":"J Exp Med"},{"key":"key20180107151614_b4-mco-01-04-0675","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"Park","year":"2005","journal-title":"Nat Immunol"},{"key":"key20180107151614_b5-mco-01-04-0675","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1002\/art.22866","article-title":"Distinct regulation of interleukin-17 in human T helper lymphocytes","volume":"56","author":"Chen","year":"2007","journal-title":"Arthritis Rheum"},{"key":"key20180107151614_b6-mco-01-04-0675","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/eji.200838748","article-title":"TGF-beta indirectly favors the development of Th17 cells by inhibiting Th1 cells","volume":"39","author":"Santarlasci","year":"2009","journal-title":"Eur J Immunol"},{"key":"key20180107151614_b7-mco-01-04-0675","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.immuni.2004.08.018","article-title":"Interleukin-17 family members and inflammation","volume":"21","author":"Kolls","year":"2004","journal-title":"Immunity"},{"key":"key20180107151614_b8-mco-01-04-0675","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1136\/gut.2008.163667","article-title":"Crohn\u2019s disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn\u2019s disease","volume":"58","author":"Brand","year":"2009","journal-title":"Gut"},{"key":"key20180107151614_b9-mco-01-04-0675","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.immuni.2009.08.012","article-title":"Intestinal effector T cells in health and disease","volume":"31","author":"Maynard","year":"2009","journal-title":"Immunity"},{"key":"key20180107151614_b10-mco-01-04-0675","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.critrevonc.2010.02.004","article-title":"Targeting immune suppressing myeloid-derived suppressor cells in oncology","volume":"77","author":"Kao","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"key":"key20180107151614_b11-mco-01-04-0675","doi-asserted-by":"crossref","first-page":"989","DOI":"10.4049\/jimmunol.172.2.989","article-title":"Antigen-specific inhibition of CD8+T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species","volume":"172","author":"Kusmartsev","year":"2004","journal-title":"J Immunol"},{"key":"key20180107151614_b12-mco-01-04-0675","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4049\/jimmunol.166.1.678","article-title":"Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer","volume":"166","author":"Almand","year":"2001","journal-title":"J Immunol"},{"key":"key20180107151614_b13-mco-01-04-0675","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/clpt.2009.312","article-title":"Cancer and inflammation: implications for pharmacology and therapeutics","volume":"87","author":"Balkwill","year":"2010","journal-title":"Clin Phamacol Ther"},{"key":"key20180107151614_b14-mco-01-04-0675","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"key20180107151614_b15-mco-01-04-0675","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nature10957","article-title":"Pathogen-induced human TH17 cells produce IFN\u03b3 or IL-10 and are regulated by IL-1\u03b2","volume":"484","author":"Zielinski","year":"2012","journal-title":"Nature"},{"key":"key20180107151614_b16-mco-01-04-0675","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nature06878","article-title":"TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function","volume":"453","author":"Zhou","year":"2008","journal-title":"Nature"},{"key":"key20180107151614_b17-mco-01-04-0675","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/bjc.2011.100","article-title":"Neutrophil\/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer","volume":"104","author":"Chua","year":"2011","journal-title":"Br J Cancer"},{"key":"key20180107151614_b18-mco-01-04-0675","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/SPC.0b013e32830f47e4","article-title":"Cyclooxygenase-2 inhibitors and antioxidants in the treatment of cachexia","volume":"2","author":"Mantovani","year":"2008","journal-title":"Curr Opin Support Palliat Care"},{"key":"key20180107151614_b19-mco-01-04-0675","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1136\/gut.52.10.1479","article-title":"Effect of a protein and energy dense: N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomized double blind trial","volume":"52","author":"Fearon","year":"2003","journal-title":"Gut"},{"key":"key20180107151614_b20-mco-01-04-0675","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fimmu.2012.00129","article-title":"TH17 cells in autoimmunity and immunodeficiency: Protective or pathogenic?","volume":"3","author":"Marwaha","year":"2012","journal-title":"Front Immunol"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mco.2013.134\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T15:16:43Z","timestamp":1515338203000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mco.2013.134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,27]]},"references-count":20,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,5,27]]},"published-print":{"date-parts":[[2013,7]]}},"alternative-id":["10.3892\/mco.2013.134"],"URL":"https:\/\/doi.org\/10.3892\/mco.2013.134","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,27]]}}}